IL15 and cancer: This approach also directly boosts the killing ability of CAR-NK cells through the localized production of specific cytokines (e.g., IL-15), allowing them to eliminate cancer cells and cancer-associated fibroblasts, disrupt solid tumor structures and enhance therapeutic effects.